Cargando…
Activation of Phosphatidylcholine-Specific Phospholipase C in Breast and Ovarian Cancer: Impact on MRS-Detected Choline Metabolic Profile and Perspectives for Targeted Therapy
Elucidation of molecular mechanisms underlying the aberrant phosphatidylcholine cycle in cancer cells plays in favor of the use of metabolic imaging in oncology and opens the way for designing new targeted therapies. The anomalous choline metabolic profile detected in cancer by magnetic resonance sp...
Autores principales: | Podo, Franca, Paris, Luisa, Cecchetti, Serena, Spadaro, Francesca, Abalsamo, Laura, Ramoni, Carlo, Ricci, Alessandro, Pisanu, Maria Elena, Sardanelli, Francesco, Canese, Rossella, Iorio, Egidio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969288/ https://www.ncbi.nlm.nih.gov/pubmed/27532027 http://dx.doi.org/10.3389/fonc.2016.00171 |
Ejemplares similares
-
Inhibition of phosphatidylcholine-specific phospholipase C downregulates HER2 overexpression on plasma membrane of breast cancer cells
por: Paris, Luisa, et al.
Publicado: (2010) -
Phosphatidylcholine-specific phospholipase C inhibition reduces HER2-overexpression, cell proliferation and in vivo tumor growth in a highly tumorigenic ovarian cancer model
por: Paris, Luisa, et al.
Publicado: (2017) -
Inhibition of phosphatidylcholine-specific phospholipase C results in loss of mesenchymal traits in metastatic breast cancer cells
por: Abalsamo, Laura, et al.
Publicado: (2012) -
Key Players in Choline Metabolic Reprograming in Triple-Negative Breast Cancer
por: Iorio, Egidio, et al.
Publicado: (2016) -
Phosphatidylcholine-specific phospholipase C inhibition down- regulates CXCR4 expression and interferes with proliferation, invasion and glycolysis in glioma cells
por: Mercurio, Laura, et al.
Publicado: (2017)